Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 3/20 | 0.69 |
| ▸ | CDK4 | P11802 | 3/20 | 0.69 |
| ▸ | CCND1 | P24385 | 3/20 | 0.69 |
| ▸ | CCNE2 | O96020 | 2/20 | 0.69 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.69 |
| ▸ | CAMK2D | Q13557 | 2/20 | 0.65 |
| ▸ | PRKACA | P17612 | 4/20 | 0.59 |
| ▸ | PRKACG | P22612 | 4/20 | 0.59 |
| ▸ | PRKACB | P22694 | 4/20 | 0.59 |
| ▸ | PIM1 | P11309 | 2/20 | 0.56 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.56 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.56 |
| ▸ | CDK9 | P50750 | 1/20 | 0.56 |
| ▸ | PRKCA | P17252 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8162775 | 0.79 | PRKACA (0.63) | CDK2CDK4CCND1CCNE2CCNE1 | |
| SCHEMBL14522482 | 0.79 | GSK3B (0.69) | CDK2CDK4CCND1CCNE2CCNE1 | |
| SCHEMBL7815707 | 0.78 | CDK4 (0.73) | CDK2CDK4CCND1CCNE2CCNE1 | |
| SCHEMBL9085908 | 0.77 | PRKACA (0.80) | CDK2CDK4CCND1CCNE2CCNE1 | |
| SCHEMBL7873644 | 0.77 | PRKACA (0.80) | CDK2CDK4CCND1CAMK2DPRKACA | |
| SCHEMBL8161322 | 0.76 | CCNE2 (0.74) | CDK2CDK4CCND1CCNE2CCNE1 | |
| SCHEMBL28659415 | 0.76 | GSK3B (0.66) | CDK2CDK4CCND1CCNE2CCNE1 | |
| SCHEMBL8166825 | 0.76 | SIRT2 (0.68) | CDK2CDK4CCND1CCNE2CCNE1 | |
| SCHEMBL28101197 | 0.75 | CCNE2 (0.53) | CDK2CDK4CCND1CCNE2CCNE1 | |
| SCHEMBL7815817 | 0.75 | PRKACA (0.63) | CDK2CDK4CCND1CCNE2CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE36736-E | Substituted pyrroles | HOFFMAN-LA ROCHE INC. (US) | 2000-06-13 | — | — | US | disclosed |
| EP-0328026-B1 | SUBSTITUTED PYRROLES | F. HOFFMANN-LA ROCHE AG (CH) | 1993-04-28 | — | — | EP | disclosed |
| US-5057614-A | Antiinflammatory, immunology, bronchodilator agents, cardiovascular disorders | HOFFMANN-LA ROCHE INC. (US) | 1991-10-15 | — | — | US | disclosed |
| EP-0328026-A1 | Substituted pyrroles | F. HOFFMANN-LA ROCHE AG (CH) | 1989-08-16 | — | — | EP | disclosed |